LNAI
Lunai Bioworks Inc.
+0.18 (+8.29%)2.35USD14.5K成交股數85.2M市值1.1本益比(近四季)1621.3股價營收比–營收年增(近四季)2026-09-28下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 6 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 21K | – | – | – | – | – | – | – | 16K | 8K | 7K | −143K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | 21K | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | 100.0% | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 16K | 46K | 24K | – | – | 161K | 390K | 1.1M | 621K | 567K | 995K | 239K |
| 銷售管理費用 | 1.4M | 1.8M | 2.4M | 4.0M | 4.2M | 4.4M | 5.3M | 7.7M | 3.6M | 8.3M | 3.0M | 3.8M |
| 營業利益 | −1.5M-65% | −1.8M-60% | −3.3M-94% | −127M+147% | −4.2M-3% | −4.5M-49% | −53.3M+133% | −51.4M+1164% | −4.3M | −8.9M | −22.9M | −4.1M |
| 營業利益率 | -7,054.1% | – | – | – | – | – | – | – | -26,791.8% | -106,079.0% | -313,404.9% | 2,850.1% |
| 稅後淨利 | −2.6M-1459% | −1.8M-75% | 2.8M-106% | −127M+115% | 189K-104% | −7.3M-21% | −44.2M+91% | −59.0M+1263% | −4.5M | −9.2M | −23.2M | −4.3M |
| 淨利率 | -12,278.6% | – | – | – | – | – | – | – | -28,417.1% | -109,552.6% | -317,002.6% | 3,035.9% |
| 稀釋 EPS | -0.10 | -0.08-82% | 0.13-105% | 2.13-494% | 0.00-100% | -0.45+221% | -2.76+573% | -0.54+575% | -0.07 | -0.14 | -0.41 | -0.08 |
| 稀釋股數 | 25.0M | 23.5M | 22.5M | 165M | 16.4M | 16.2M | 16.0M | 109M | 65.9M | 64.5M | 56.3M | 56.0M |
資產負債表 期末餘額
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 3.2M | 492K | 625K | 93K | 923K | 312K | 221K | 313K | 244K | 523K | 1.9M | 2.9M |
| 應收帳款 | – | – | – | – | 964K | – | – | – | 1.1M | 1.1M | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 9.9M | 6.7M | 7.0M | 8.2M | 118M | 111M | 122M | 178M | 58.0M | 57.6M | 58.3M | 78.7M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 19.4M | 20.2M | 20.0M | 29.6M | 29.3M | 29.3M | 23.7M | 43.7M | 14.4M | 10.8M | 11.8M | 12.6M |
| 股東權益 | −9.6M | −13.5M | −13.0M | −21.3M | 88.4M | 82.1M | 98.1M | 134M | 43.6M | 46.7M | 46.5M | 66.1M |
| 負債比 | 196.9% | 303.2% | 287.3% | 359.4% | 24.9% | 26.3% | 19.5% | 24.5% | 24.9% | 18.8% | 20.2% | 16.0% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | – | −1.3M-33% | – | – | – | −2.0M | – | – | −2.8M | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | 11K | 11K | 42K | 33K | 32K | 32K | 32K | 30K | 33K | 27K | 28K | 28K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −178M | –% | -1.08 | – |
| FY2024 | – | – | −88.4M | –% | -0.91 | −11.0M |
| FY2023 | −127K | -203.8% | −39.7M | 31,341.1% | -0.71 | −11.8M |
| FY2022 | 122K | – | −113M | -92,947.0% | -2.16 | −15.7M |
| FY2021 | – | – | −26.7M | –% | -0.57 | −20.7M |
| FY2020 | – | – | −11.4M | –% | -0.25 | −10.6M |
| FY2019 | – | – | −18.0M | –% | -0.48 | −9.2M |